BIIB

$0.00

(

0.00%

)
Quote details

stock

Biogen Inc

NASDAQ | BIIB

142.63

USD

$0.00

(

0.00%

)

At Close (As of Oct 15, 2025)

$21.30B

Market Cap

13.85

P/E Ratio

10.49

EPS

$191.19

52 Week High

$110.04

52 Week Low

HEALTHCARE

Sector

BIIB Chart

Recent Chart
Price Action

BIIB Technicals

Tags:

BIIB Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $7.4B
Total Revenue $9.7B
Cost Of Revenue $2.3B
Costof Goods And Services Sold $2.3B
Operating Income $2.2B
Selling General And Administrative $2.4B
Research And Development $2B
Operating Expenses $5.1B
Investment Income Net -
Net Interest Income -$183M
Interest Income $68M
Interest Expense $250M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $673M
Income Before Tax $1.9B
Income Tax Expense $274M
Interest And Debt Expense -
Net Income From Continuing Operations $1.6B
Comprehensive Income Net Of Tax -
Ebit $2.2B
Ebitda $2.8B
Net Income $1.6B

Revenue & Profitability

Earnings Performance

BIIB Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $28B
Total Current Assets $7.5B
Cash And Cash Equivalents At Carrying Value $2.4B
Cash And Short Term Investments $2.4B
Inventory $2.5B
Current Net Receivables $1.9B
Total Non Current Assets $21B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $9.7B
Intangible Assets Excluding Goodwill $9.7B
Goodwill $6.5B
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $753M
Other Non Current Assets -
Total Liabilities $11B
Total Current Liabilities $5.5B
Current Accounts Payable $424M
Deferred Revenue -
Current Debt -
Short Term Debt $1.7B
Total Non Current Liabilities $5.8B
Capital Lease Obligations $335M
Long Term Debt $4.5B
Current Long Term Debt $1.7B
Long Term Debt Noncurrent -
Short Long Term Debt Total $6.6B
Other Current Liabilities $2.8B
Other Non Current Liabilities $732M
Total Shareholder Equity $17B
Treasury Stock -
Retained Earnings $19B
Common Stock $100K
Common Stock Shares Outstanding $146M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $2.9B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $673M
Capital Expenditures $360M
Change In Receivables -
Change In Inventory -$274M
Profit Loss -
Cashflow From Investment -$799M
Cashflow From Financing -$684M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $1.6B

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $7.4B
Total Revenue $9.7B
Cost Of Revenue $2.3B
Costof Goods And Services Sold $2.3B
Operating Income $2.2B
Selling General And Administrative $2.4B
Research And Development $2B
Operating Expenses $5.1B
Investment Income Net -
Net Interest Income -$183M
Interest Income $68M
Interest Expense $250M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $673M
Income Before Tax $1.9B
Income Tax Expense $274M
Interest And Debt Expense -
Net Income From Continuing Operations $1.6B
Comprehensive Income Net Of Tax -
Ebit $2.2B
Ebitda $2.8B
Net Income $1.6B

BIIB News

BIIB Profile

Biogen Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

Biogen Inc. is a premier American biotechnology company headquartered in Cambridge, Massachusetts, specializing in the discovery and development of transformative therapies for neurological disorders. With a robust pipeline targeting critical conditions like multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, Biogen is at the forefront of addressing significant unmet medical needs. The company is dedicated to advancing therapeutic innovation and enhancing patient outcomes through strategic collaborations and a strong commitment to scientific research, solidifying its position as a leader in the biotechnology sector.

VHAI
0.00%
$0.00
GNPX
+206.61%
$0.77
YYAI
-4.53%
$0.14
VIVK
+41.64%
$0.26
CGBS
-39.47%
$0.03
BURU
-23.95%
$0.31
NVTS
+26.07%
$12.57
COOT
+248.18%
$3.36
DFLI
+45.75%
$2.23
NVDA
-0.01%
$180.00
CAN
-5.27%
$1.70
PLUG
-7.40%
$3.75
BITF
+2.56%
$6.04
OMER
+148.17%
$10.17
LAES
-9.86%
$6.89
ACHR
+1.95%
$13.02
TLRY
-5.32%
$1.60
TOVX
+34.85%
$0.58
RGTI
-5.66%
$52.93
AXDX
-61.36%
$0.03
AMD
+7.47%
$234.39
RXRX
+8.23%
$6.37
DNN
-1.88%
$3.13
NEHC
+30.63%
$3.07
NUAI
+30.63%
$3.07
RR
-6.25%
$6.30
QS
+3.67%
$17.50
PFAI
+82.98%
$3.49
YDKG
-85.89%
$0.19
USAR
-2.93%
$37.54
QBTS
+0.69%
$43.36
BYND
+2.67%
$0.80
ETHD
+6.19%
$3.76
TSLA
+0.97%
$433.41
INTC
+2.04%
$36.35
FHN
-11.25%
$20.42
SNAP
-1.61%
$7.92
SMR
+11.60%
$51.10
QSI
+14.18%
$2.45
RMBL
+60.50%
$3.21
F
+0.60%
$11.72
MARA
+1.12%
$22.49
ADD
-25.47%
$0.05
ADAP
+11.81%
$0.17
ATCH
+3.66%
$0.41
JBLU
+7.91%
$4.91
SEED
+42.16%
$2.04
GDXD
-10.55%
$0.67
SRM
+53.27%
$10.30
DVLT
-2.51%
$2.13
BAC
+4.54%
$52.36
IONZ
+9.37%
$2.81
UUUU
-6.59%
$24.50
SOFI
+2.07%
$28.44
KDLY
-7.78%
$0.78
VERI
+54.48%
$8.43
QUBT
+0.13%
$21.81
IREN
-2.64%
$67.72
NAK
-2.89%
$2.68
CRML
-22.52%
$23.22
SOUN
+1.15%
$21.10
CIFR
+0.23%
$20.94
ONDS
-7.78%
$9.59
APLD
+6.29%
$37.24
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NOK
+1.64%
$5.56
RIG
+3.04%
$3.21
WLGS
-5.57%
$0.04
BBD
+1.11%
$3.18
SLNH
+20.60%
$3.36
GPUS
-5.64%
$0.38
BTG
+5.75%
$5.64
TMQ
-19.33%
$8.55
ETWO
0.00%
$3.30
UAMY
-21.17%
$13.77
REKR
+21.15%
$2.52
OKLO
+1.83%
$174.14
LGO
-39.68%
$1.52
CLSK
+2.79%
$22.59
TBH
+10.39%
$1.11
WWR
-32.18%
$2.36
RGTZ
+14.09%
$10.03
BTBT
-1.59%
$4.06
AAL
+0.98%
$12.30
WULF
+0.71%
$15.57
ABAT
-21.30%
$8.91
AFMD
-34.94%
$0.18
AREC
-27.82%
$4.91
AMZN
-0.42%
$215.46
NIO
+0.44%
$6.83
SANA
+31.68%
$5.86
IBG
+33.51%
$4.29
TE
+16.86%
$4.68
WOK
-16.24%
$0.06
BMNR
-0.94%
$52.42
EOSE
+3.73%
$17.61
NAKA
-1.53%
$0.77
OPI
-16.97%
$0.20
ASST
-4.68%
$0.95
VHAI
0.00%
$0.00
GNPX
+206.61%
$0.77
YYAI
-4.53%
$0.14
VIVK
+41.64%
$0.26
CGBS
-39.47%
$0.03
BURU
-23.95%
$0.31
NVTS
+26.07%
$12.57
COOT
+248.18%
$3.36
DFLI
+45.75%
$2.23
NVDA
-0.01%
$180.00
CAN
-5.27%
$1.70
PLUG
-7.40%
$3.75
BITF
+2.56%
$6.04
OMER
+148.17%
$10.17
LAES
-9.86%
$6.89
ACHR
+1.95%
$13.02
TLRY
-5.32%
$1.60
TOVX
+34.85%
$0.58
RGTI
-5.66%
$52.93
AXDX
-61.36%
$0.03
AMD
+7.47%
$234.39
RXRX
+8.23%
$6.37
DNN
-1.88%
$3.13
NEHC
+30.63%
$3.07
NUAI
+30.63%
$3.07
RR
-6.25%
$6.30
QS
+3.67%
$17.50
PFAI
+82.98%
$3.49
YDKG
-85.89%
$0.19
USAR
-2.93%
$37.54
QBTS
+0.69%
$43.36
BYND
+2.67%
$0.80
ETHD
+6.19%
$3.76
TSLA
+0.97%
$433.41
INTC
+2.04%
$36.35
FHN
-11.25%
$20.42
SNAP
-1.61%
$7.92
SMR
+11.60%
$51.10
QSI
+14.18%
$2.45
RMBL
+60.50%
$3.21
F
+0.60%
$11.72
MARA
+1.12%
$22.49
ADD
-25.47%
$0.05
ADAP
+11.81%
$0.17
ATCH
+3.66%
$0.41
JBLU
+7.91%
$4.91
SEED
+42.16%
$2.04
GDXD
-10.55%
$0.67
SRM
+53.27%
$10.30
DVLT
-2.51%
$2.13
BAC
+4.54%
$52.36
IONZ
+9.37%
$2.81
UUUU
-6.59%
$24.50
SOFI
+2.07%
$28.44
KDLY
-7.78%
$0.78
VERI
+54.48%
$8.43
QUBT
+0.13%
$21.81
IREN
-2.64%
$67.72
NAK
-2.89%
$2.68
CRML
-22.52%
$23.22
SOUN
+1.15%
$21.10
CIFR
+0.23%
$20.94
ONDS
-7.78%
$9.59
APLD
+6.29%
$37.24
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
NOK
+1.64%
$5.56
RIG
+3.04%
$3.21
WLGS
-5.57%
$0.04
BBD
+1.11%
$3.18
SLNH
+20.60%
$3.36
GPUS
-5.64%
$0.38
BTG
+5.75%
$5.64
TMQ
-19.33%
$8.55
ETWO
0.00%
$3.30
UAMY
-21.17%
$13.77
REKR
+21.15%
$2.52
OKLO
+1.83%
$174.14
LGO
-39.68%
$1.52
CLSK
+2.79%
$22.59
TBH
+10.39%
$1.11
WWR
-32.18%
$2.36
RGTZ
+14.09%
$10.03
BTBT
-1.59%
$4.06
AAL
+0.98%
$12.30
WULF
+0.71%
$15.57
ABAT
-21.30%
$8.91
AFMD
-34.94%
$0.18
AREC
-27.82%
$4.91
AMZN
-0.42%
$215.46
NIO
+0.44%
$6.83
SANA
+31.68%
$5.86
IBG
+33.51%
$4.29
TE
+16.86%
$4.68
WOK
-16.24%
$0.06
BMNR
-0.94%
$52.42
EOSE
+3.73%
$17.61
NAKA
-1.53%
$0.77
OPI
-16.97%
$0.20
ASST
-4.68%
$0.95

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.